Browse by Subject DRUG-RESISTANCE
Showing results 1 to 20 of 20
| Blockade of vascular endothelial growth factor sensitizes tumor-associated vasculatures to angiolytic therapy with a high-frequency ultrashort pulsed laser Choi, Hyosook; Choi, Myunghwan; Choi, Kyungsun; Choi, Chulhee, MICROVASCULAR RESEARCH, v.82, no.2, pp.141 - 146, 2011-09 |
| Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas Lee, June Koo; Lee, Junehawk; Kim, Sehui; Kim, Soyeon; Youk, Jeonghwan; Park, Seongyeol; An, Yohan; et al, JOURNAL OF CLINICAL ONCOLOGY, v.35, no.26, pp.3065 - +, 2017-09 |
Constitutive Expression of MAP Kinase Phosphatase-1 Confers Multi-drug Resistance in Human Glioblastoma Cells Yu, Ha-Na; Park, Jun-Seong; Lee, Jung-Sul; Choi, Kyung-Sun; Choi, Chul-Hee, CANCER RESEARCH AND TREATMENT, v.44, no.3, pp.195 - 201, 2012-09 |
| Enabling perfusion through multicellular tumor spheroids promoting lumenization in a vascularized cancer model Park, Joonha; Kim, Seunggyu; Hong, Jiman; Jeon, Jessie S., LAB ON A CHIP, v.22, no.22, pp.4335 - 4348, 2022-11 |
| HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer Rumman, Marufa; Jung, Kyung Hee; Fang, Zhenghuan; Yan, Hong Hua; Son, Mi Kwon; Kim, Soo Jung; Kim, Juyoung; et al, ONCOTARGET, v.7, no.47, pp.78029 - 78047, 2016-11 |
| In Vitro Optimization of EtNBS-PDT against Hypoxic Tumor Environments with a Tiered, High-Content, 3D Model Optical Screening Platform Klein, Oliver J.; Bhayana, Brijesh; Park, Yong Jin; Evans, Conor L., MOLECULAR PHARMACEUTICS, v.9, no.11, pp.3171 - 3182, 2012-11 |
| Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer Li, Meng; Balch, Curt; Montgomery, John S.; Jeong, Mikyoung; Chung, Jae Hoon; Yan, Pearlly; Huang, Tim H. M.; et al, BMC MEDICAL GENOMICS, v.2, 2009-06 |
| Intracellular annexin A2 regulates NF-kappa B signaling by binding to the p50 subunit: implications for gemcitabine resistance in pancreatic cancer Jung, H.; Kim, J. S.; Kim, W. K.; Oh, K-J; Kim, J-M; Lee, H. J.; Han, B. S.; et al, CELL DEATH & DISEASE, v.6, 2015-01 |
| Killing Hypoxic Cell Populations in a 3D Tumor Model with EtNBS-PDT Evans, Conor L.; Abu-Yousif, Adnan O.; Park, Yong Jin; Klein, Oliver J.; Celli, Jonathan P.; Rizvi, Imran; Zheng, Xiang; et al, PLOS ONE, v.6, no.8, 2011 |
| Modeling Host-Virus Interactions in Viral Infectious Diseases Using Stem-Cell-Derived Systems and CRISPR/Cas9 Technology Kim, Jihoon; Koo, Bon-Kyoung; Yoon, Ki-Jun, VIRUSES-BASEL, v.11, no.2, 2019-02 |
| Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation Aldonza, Mark Borris D; Hong, Ji-Young; Alinsug, Malona V.; Song, Jayoung; Lee, Sang Kook, ONCOTARGET, v.7, no.23, pp.34395 - 34419, 2016-06 |
| Novel participation of transglutaminase-2 through c-Jun N-terminal kinase activation in sphingosylphosphorylcholine-induced keratin reorganization of PANC-1 cells Park, Mi Kyung; Jee, Hye Ja; Shin, Jennifer Hyunjong; Noh, Minsoo; Kim, Soo You; Lee, Chang Hoon, BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, v.1811, no.12, pp.1021 - 1029, 2011-12 |
| Paclitaxel-resistant cancer cell-derived secretomes elicit ABCB1-associated docetaxel cross-resistance and escape from apoptosis through FOXO3a-driven glycolytic regulation Aldonza, Mark Borris D.; Hong, Ji-Young; Lee, Sang Kook, EXPERIMENTAL AND MOLECULAR MEDICINE, v.49, 2017-01 |
| Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms Aldonza, Mark Borris D.; Ku, Jayoung; Hong, Ji-Young; Kim, Donghwa; Yu, Seung Jung; Lee, Min-Seok; Prayogo, Monica Celine; et al, SCIENCE ADVANCES, v.6, no.6, 2020-02 |
| Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies Kim, Min Hwan; Kim, Joon, CELLULAR AND MOLECULAR LIFE SCIENCES, v.74, no.8, pp.1457 - 1474, 2017-04 |
| Strategies to overcome acquired resistances conferred by mutations in the kinase domain of EGFR Lim, Sang Min; Jeong, Yujeong; Hong, Sungwoo, FUTURE MEDICINAL CHEMISTRY, v.8, no.8, pp.853 - 878, 2016-05 |
| Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy Kim, B.; Wang, S.; Lee, Ji Min; Jeong, Y.; Ahn, T.; Son, D-S; Park, H. W.; et al, ONCOGENE, v.34, no.9, pp.1083 - 1093, 2015-02 |
| Systems analysis identifies potential target genes to overcome cetuximab resistance in colorectal cancer cells Park, Sang-Min; Hwang, Chae Young; Cho, Sung-Hwan; Lee, Daewon; Gong, Jeong-Ryeol; Lee, Soobeom; Nam, Sohee; et al, FEBS JOURNAL, v.286, no.7, pp.1305 - 1318, 2019-04 |
| The urgent need for microbiology literacy in society Timmis, Kenneth; Cavicchioli, Ricardo; Garcia, Jose Luis; Nogales, Balbina; Chavarria, Max; Stein, Lisa; McGenity, Terry J.; et al, ENVIRONMENTAL MICROBIOLOGY, v.21, no.5, pp.1513 - 1528, 2019-05 |
| Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption Kim, Chan; Yang, Hanseul; Fukushima, Yoko; Saw, Phei Er; Lee, Junyeop; Park, Jin-Sung; Park, Intae; et al, CANCER CELL, v.25, no.1, pp.102 - 117, 2014-01 |
Discover
Type
Open Access
Date issued
- 34,203 2020 - 2024
- 100,102 2010 - 2019
- 75,680 2000 - 2009
- 44,727 1990 - 1999
- 14,360 1980 - 1989
- 62 1964 - 1969